Sort
261,768 grants matching “gene therapy”
Solving the Valence Assignment Problem
$937,975Kay Maxine Tye · Salk Institute For Biological Studies · R37 · FY2023 · MH
Solving the Valence Assignment Problem
$937,975Kay Maxine Tye · Salk Institute For Biological Studies · R37 · FY2024 · MH
Solving the Valence Assignment Problem
$937,975Kay Maxine Tye · Salk Institute For Biological Studies · R37 · FY2025 · MH
Solving the Valence Assignment Problem
$937,975Kay Maxine Tye · Salk Institute For Biological Studies · R37 · FY2021 · MH
Solving the Valence Assignment Problem
$937,975Kay Maxine Tye · Salk Institute For Biological Studies · R37 · FY2022 · MH
The connection of innate and adaptive anti-cancer immunity
$937,885John Greiner · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Integrative approaches to elucidate p53 transcriptional networks during carcinogenesis
$937,837Laura D Attardi · Stanford University · R35 · FY2023 · CA
Next generation hybrid nucleases for precise excision of latent HIV-1 provirus
$937,745Jeremy Luban · Univ Of Massachusetts Med Sch Worcester · R01 · FY2019 · AI
Next generation hybrid nucleases for precise excision of latent HIV-1 provirus
$937,745Jeremy Luban · Univ Of Massachusetts Med Sch Worcester · R01 · FY2018 · AI
Systems biology of HIV, methamphetamine and antiretrovirals interactions
$937,707Pietro P Sanna · Scripps Research Institute, The · R01 · FY2016 · DA
From pathogenesis to new therapeutic targets in diffuse large B cell lymphoma
$937,650Riccardo Dalla-Favera · Columbia University Health Sciences · R35 · FY2024 · CA
Molecular Pathogenesis of Neoplasia
$937,516Richard Youle · National Institute Of Neurological Disorders And Stroke · ZIA · FY2019 · NS
Stem Cell Biology, Cancer Stem Cell Biology, and Cancer Immunotherapy
$937,462Irving Lerner Weissman · Stanford University · R35 · FY2020 · CA
Disease mechanism and therapies for retinal degeneration
$937,456Tiansen Li · National Eye Institute · ZIA · FY2011 · EY
RECOMBINANT AAV FOR CORRECTION OF GENETIC ABNORMALITIES
$937,381University Of Florida · P01 · FY2000 · DK
Chemical Genomics Paradigm for Epigenetic Regulation
$937,377Ming-Ming Zhou · Icahn School Of Medicine At Mount Sinai · R01 · FY2011 · HG
Chemical Genomics Paradigm for Epigenetic Regulation
$937,377Ming-Ming Zhou · Icahn School Of Medicine At Mount Sinai · R01 · FY2010 · HG
Role of 11q23 Chromosome Abnormalities in the Causation of Acute Leukemia
$937,343Carlo M Croce · Ohio State University · P01 · FY2012 · CA
Predicting Cancer Cell Response to Endogenous and Exogenous Perturbations at the Single Cell Level
$937,314Andrea Califano · Columbia University Health Sciences · R35 · FY2024 · CA
WHICH ISOTYPE OF ECD4-IG MOST EFFECTIVELY SUPPRESSES VIRUS REPLICATION?
$937,245Michael David Alpert · Emmune, Inc · R44 · FY2017 · AI
he 3D Platelet Bank: A Clinical-grade, Scalable, 3D Microbioreactor Bone Marrow Mimetic for Platelet Production
$937,164Teresa Marie Desrochers · Kiyatec, Inc. · R44 · FY2017 · EB
Mechanisms of Immune-mediated Tumor Cell Destruction
$937,072Thomas J. Sayers · Basic Sciences · Z01 · FY2007 · CA
A Pharmacochaperone-based strategy for identifying chemical probes of brain-derived orphan GPCRs
$936,860Layton Harris Smith · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2020 · MH
2/2 A Phase 2 Study of Elafin (Tiprelestat) for the Treatment of Pulmonary Arterial Hypertension (PAH)
$936,858Catherine A Spino · University Of Michigan At Ann Arbor · U24 · FY2025 · HL
Molecular diagnosis and outcome prediction in lymphoma
$936,810Louis Staudt · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA